Abstract
This paper presents the results of an optimization study on biaryl piperidine and 4-amino-2-biarylurea MCH1 receptor antagonists, which was accomplished by using quantitative-structure activity relationships (QSARs), classification and virtual screening techniques. First, a linear QSAR model was developed using Multiple Linear Regression (MLR) Analysis, while the Elimination Selection-Stepwise Regression (ES-SWR) method was adopted for selecting the most suitable input variables. The predictive activity of the model was evaluated using an external validation set and the Y-randomization technique. Based on the selected descriptors, the Support Vector Machines (SVM) classification technique was utilized to classify data into two categories: “actives” or “non-actives”. Several attempts were made to optimize the scaffold of most potent compounds by inducing various structural modifications. Potential derivatives with improved activities were identified, as they were classified “actives” by the SVM classifier. Their activities were estimated using the produced MLR model. A detailed analysis on the model applicability domain defined the compounds, whose estimations can be accepted with confidence.

Similar content being viewed by others
References
Kowalski TJ, Spar BD, Weig B, Farley C, Cook J, Ghibaudi L, Fried S, O’Neill K, Del Vecchio RA, McBriar M, Guzik H, Clader J, Hawes BE, Hwa J (2006) Eur J Pharmacol 535:182
McBriar M, Guzik H, Shapiro S, Paruchova J, Xu R, Palani A, Clader JW, Cox K, Greenlee WJ, Hawes BE, Kowalski TJ, O’Neill K, Spar BD, Weig B, Weston DJ, Farley C, Cook J (2006) J Med Chem 49:2294
(a) Palani A, Shapiro S, McBriar MD, Clader JW, Greenlee WJ, Spar B, Kowalski TJ, Farley C, Cook J, van Heek M, Weig B, O’Neill K, Graziano M, Hawes B (2005) J Med Chem 48:4746. (b) McBriar MD, Guzik H, Xu R, Paruchova J, Li S, Palani A, Clader JW, Greenlee WJ, Hawes BE, Kowalski TJ, O’Neill K, Spar B, Weig B (2005) J Med Chem 48:2274
Receveur JM, Bjurling E, Ulven T, Little PB, Norregaard PK, Hogberg T (2004) Bioorg Med Chem Lett 14:5075
Rowbottom MW, Vickers TD, Dyck B, Taminiya J, Zhang M, Zhao L, Grey J, Provencal D, Schwarz D, Heise CE, Mistry M, Fisher A, Dong T, Hu T, Saunders J, Goodfellow VS (2005) Bioorg Med Chem Lett 15:3439
Vasudevan A, Wodka D, Verzal MK, Souers AJ, Gao J, Brodjian S, Fry D, Dayton B, Marsh KC, Hernandez LE, Ogiela CA, Collins CA, Kym PR (2004) Bioorg Med Chem Lett 14:4879
(a) Xu R, Li S, Paruchova J, McBriar MD, Guzik H, Palani A, Clader JW, Cox K, Greenlee WJ, Hawes BE, Kowalski TJ, O’Neill K, Spar BD, Weig B, Weston DJ (2006) Bioorg Med Chem 14:3285. (b) Su J, McKittrick BA, Tang H, Czarniecki M, Greenlee WJ, Hawes BE, O’Neill K (2005) Bioorg Med Chem 13:1829
(a) Kanuma K, Omodera K, Nishiguchi M, Funakoshi T, Chaki S, Semple G, Tran T-A, Kramer B, Hsu D, Casper M, Thomsen B, Beeley N, Sekiguchi Y (2005) Bioorg Med Chem Lett 15:2565. (b) Kanuma K, Omodera K, Nishiguchi M, Funakoshi T, Chaki S, Semple G, Tran T-A, Kramer B, Hsu D, Casper M, Thomsen B, Sekiguchi Y (2005) Bioorg Med Chem Lett 15:3853. (c) Kanuma K, Omodera K, Nishiguchi M, Funakoshi T, Chaki S, Nagase Y, Iida I, Yamaguchi J-I, Semple G, Tran T-A, Sekiguchi Y (2006) Bioorg Med Chem 14:3307
Vasudevan A, Wodka D, Verzal MK, Souers AJ, Gao J, Brodjian S, Fry D, Dayton B, Marsh KC, Hernandez LE, Ogiela CA, Collins CA, Kym PR (2004) Bioorg Med Chem Lett 14:4879
Guo T, Hunter RC, Gu H, Shao Y, Rokosz LL, Stauffer TM, Hobbs DW (2005) Bioorg Med Chem Lett 15:3691
Guo T, Shao Y, Qian G, Rokosz LL, Stauffer TM, Hunter RC, Babu SD, Gu H, Hobbs DW (2005) Bioorg Med Chem Lett 15:3696
CambridgeSoft Corporation http://www.cambridgesoft.com
http://www.lohninger.com/topix.html
Kennard RW, Stone LA (1969) Technometrics 11:137
Tropsha A, Gramatica P, Gombar VK (2003) QSAR Comb Sci 22:69
Wu W, Walczak B, Massart DL, Heuerding S, Erni F, Last IR, Prebble KA (1996) Chemometr Intell Lab Syst 33:35
Todeschini R, Consonni V, Mannhold R, Kubinyi H, Timmerman H (Series Editor) (2000) Handbook of molecular descriptors. Wiley-VCH, Weinheim
(a) Efron B (1983) J Am Stat Assoc 78:316. (b) Osten DW (1998) J Chemom 2:39
Shen M, Beguin C, Golbraikh A, Stables J, Kohn H, Tropsha A (2004) J Med Chem 47:2356
Golbraikh A, Tropsha A (2002) J Mol Graph Mod 20:269
Wold S, Eriksson L (1995) In: Van de Waterbeemd H (ed) Chemometrics methods in molecular design, VCH Weinheim, Germany
Atkinson A (1985) Plots, transformations and regression. Clarendon Press, Oxford (UK)
Cortes C, Vapnik V (1995) Mach Learning 20:273
Jorissen RN, Gilson MK (2005) J Chem Inf Model 45:549
Wilton D, Willet P, Lawson K, Mullier G (2003) J Chem Inf Comput Sci 43:469
Chang CC, Lin CJ LIBSVM: http://www.csie.ntu.edu.tw/∼cjlin/libsvm
Burges CJC (1998) Data Min Knowl Discov 2:127
Walters WPA, Murcko MA (1999) Curr Opin Chem Biol 3:384
Karelson M (2000) Molecular descriptors in QSAR/QSPR. Wiley, NY
Kier LB, Hall LB (1986) Molecular connectivity in structure activity analysis. Wiley, Chichester
Afantitis A, Melagraki G, Sarimveis H, Koutentis PA, Markopoulos J, Igglessi-Markopoulou O (2006) J Comput Aid Design 20:83
Afantitis A, Melagraki G, Sarimveis H, Koutentis PA, Markopoulos J, Igglessi-Markopoulou O (2006) Mol Div. 10:405
Acknowledgments
G.M. thanks the Greek State Scholarship Foundation for a doctoral assistantship. A.A. wishes to thank Cyprus Research Promotion Foundation (Grant No. PENEK/ENISX/0603/05) and the Committee of Research of the National Technical University of Athens, Greece for a doctoral assistantship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Melagraki, G., Afantitis, A., Sarimveis, H. et al. Optimization of biaryl piperidine and 4-amino-2-biarylurea MCH1 receptor antagonists using QSAR modeling, classification techniques and virtual screening. J Comput Aided Mol Des 21, 251–267 (2007). https://doi.org/10.1007/s10822-007-9112-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-007-9112-4